Update on treatments for anxiety-related disorders
The DOI matches its Crossref record; 65 of the 70 references it cites were found in a registry or an index.
Abstract
Purpose of reviewThis review examines recent evidence that informs the treatment of anxiety-related disorders.Recent findingsIn addition to selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and benzodiazepines, agomelatine has demonstrated efficacy in treating generalized anxiety disorder (GAD). Other novel products, such as ketamine, psilocybin and cannabidiol, are in the process of gathering evidence in support of the treatment of anxiety disorders. In psychological therapy, various psychological treatments for anxiety disorders, such as mindfulness-based intervention, acceptance and commitment therapy, psychodynamic therapy, emotion-focused therapy and dialectical behavioural therapy, have been tried. Still, most therapies have not proven superior to cognitive behavioural therapy (CBT). In very preliminary findings: Repetitive transcranial magnetic stimulation (rTMS) was effective in GAD; transcranial direct current stimulation (tDCS) was effective for social anxiety disorder (SAD) and GAD and augmented exposure therapy for specific fears. Internet and mobile-based interventions have comparable efficacy to face-to-face therapy.SummaryPharmacotherapy of anxiety disorders is expanding to novel products. Despite trying other psychological therapies for anxiety disorders, most therapies were comparable to but not superior to CBT. rTMS and tDCS were also used and show early promise for GAD, but further studies are needed. Most internet or mobile app based psychological therapies were based on CBT, and some can be considered as alternatives to in-person face-to-face therapy. © 2023 Lippincott Williams and Wilkins. All rights reserved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Yang, X., Fang, Y., Chen, H., Zhang, T., Yin, X., Man, J., Yang, L., & Lu, M. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000275 · Cited by 458
Stein, M. B., & Sareen, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1502514 · Cited by 314
Self-citationThe Therapeutic Potential of Psilocybin
Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 242
Fernandez, E., Woldgabreal, Y., Day, A., Pham, T., Gleich, B., & Aboujaoude, E. (2021) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2594 · Cited by 167 · cited 1×
“Video-delivered psychotherapy showed significantly better outcomes than the waitlist group but a negligible difference from in-person psychotherapy [57].”
Backgroundvan Loenen, I., Scholten, W., Muntingh, A., Smit, J., & Batelaan, N. (2022) · Journal of Medical Internet Research · doi:10.2196/26736 · Cited by 153
Potential Applications of Social Robots in Robot-Assisted Interventions for Social Anxiety
Rasouli, S., Gupta, G., Nilsen, E., & Dautenhahn, K. (2022) · International Journal of Social Robotics · doi:10.1007/s12369-021-00851-0 · Cited by 144
Haller, H., Breilmann, P., Schröter, M., Dobos, G., & Cramer, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-99882-w · Cited by 126
Simon, N. M., Hofmann, S. G., Rosenfield, D., Hoeppner, S. S., Hoge, E. A., Bui, E., & Khalsa, S. B. S. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2496 · Cited by 95 · cited 1×
“However, the noninferiority test did not find Kundalini yoga to be as effective as CBT [38].”
Background
Cited by
Zheng, E. Z., Wong, N. M. L., Yang, A. S. Y., & Lee, T. M. C. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03003-w · Cited by 72
“Furthermore, although the evidence is not as robust, tDCS has also shown promising results in the treatment of anxiety disorders such as Generalized Anxiety Disorder (GAD) and Social Anxiety Disorder (SAD) [20, 30].”
BackgroundMindfulness-Based Interventions and the Hypothalamic–Pituitary–Adrenal Axis: A Systematic Review
Vargas‐Uricoechea, H., Castellanos-Pinedo, A., Urrego-Noguera, K., Vargas-Sierra, H. D., Fernández, M. V. P., Barceló, E., & Giraldo, A. F. R. (2024) · Neurology International · doi:10.3390/neurolint16060115 · Cited by 62
Xie, L., Hu, P., Guo, Z., Chen, M., Wang, X., Du, X., Li, Y., Chen, B., Zhang, J., Zhao, W., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03053-0 · Cited by 33
“Thirdly, the number of randomized controlled studies on tDCS for OCD, PTSD, and ADs is limited, so we are unable to control for comorbidities or other interventions.”
Martins, M. L., Pinheiro, E. F., Saito, G. A., Lima, C. A. C. D., Leão, L. K. R., Batista, E. D. J. O., Passos, A. D. C. F., Gouvêia, A., Oliveira, K. R. H. M., & Herculano, A. M. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1464992 · Cited by 20
“Furthermore, due to the involvement of other neurotransmission systems, such as noradrenergic and serotonergic, antidepressants are also frequently prescribed (Fluyau et al., 2022; Lee and Stein, 2023).”
BackgroundYang, X., Ma, L., Fan, C. G., Wang, H., Zhang, M., Du, H., Zhou, T., & Li, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.071 · Cited by 20
Metadata
- Authors
- Lee, H. J., & Stein, M. B.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Stein, Murray B.
- Venue
- Current Opinion in Psychiatry
- Published
- 2022-12-06
- Volume
- 36
- Issue
- 2
- Pages
- 140-145
- ISSN
- 0951-7367 (ISSN-L)
- 1473-6578
- OpenAlex
- W4310945038
- Cited by
- 43
- References
- 70
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 13 · 2023: 5
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- anxiety disorders, generalized anxiety disorder, social anxiety disorder, pharmacotherapy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, benzodiazepines, agomelatine, ketamine, psilocybin, cannabidiol, cognitive behavioral therapy, mindfulness-based interventions, acceptance and commitment therapy, psychodynamic psychotherapy, emotion-focused therapy, dialectical behavior therapy, repetitive transcranial magnetic stimulation, transcranial direct current stimulation, exposure therapy, online intervention, mobile-based interventions
- MeSH terms
- Anxiety, Anxiety Disorders, Humans, Selective Serotonin Reuptake Inhibitors, Acceptance and Commitment Therapy, Transcranial Direct Current Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update on treatments for anxiety-related disorders. https://app.cochat.ai/papers/10.1097/yco.0000000000000841
- The paper
- Lee, H. J., & Stein, M. B. (2023). Update on treatments for anxiety-related disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.